vs
自然阳光（NATR）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
自然阳光的季度营收约是Resolute Holdings Management, Inc.的1.1倍（$123.8M vs $117.7M），自然阳光净利率更高（3.3% vs -1.5%，领先4.8%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $7.6M）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
NATR vs RHLD — 直观对比
营收规模更大
NATR
是对方的1.1倍
$117.7M
净利率更高
NATR
高出4.8%
-1.5%
自由现金流更多
RHLD
多$181.7M
$7.6M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $117.7M |
| 净利润 | $4.1M | $-1.7M |
| 毛利率 | 72.5% | 55.7% |
| 营业利润率 | 4.3% | 30.2% |
| 净利率 | 3.3% | -1.5% |
| 营收同比 | 4.7% | — |
| 净利润同比 | 1379.4% | — |
| 每股收益（稀释后） | $0.23 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRRHLD
| Q4 25 | $123.8M | $117.7M | ||
| Q3 25 | $128.3M | $120.9M | ||
| Q2 25 | $114.8M | $119.6M | ||
| Q1 25 | $113.2M | $103.9M | ||
| Q4 24 | $118.2M | — | ||
| Q3 24 | $114.6M | — | ||
| Q2 24 | $110.6M | — | ||
| Q1 24 | $111.0M | — |
净利润NATRRHLD
| Q4 25 | $4.1M | $-1.7M | ||
| Q3 25 | $5.3M | $-231.0K | ||
| Q2 25 | $5.3M | $-611.0K | ||
| Q1 25 | $4.7M | $-3.4M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $2.3M | — |
毛利率NATRRHLD
| Q4 25 | 72.5% | 55.7% | ||
| Q3 25 | 73.3% | 59.0% | ||
| Q2 25 | 71.7% | 57.5% | ||
| Q1 25 | 72.1% | 52.5% | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
营业利润率NATRRHLD
| Q4 25 | 4.3% | 30.2% | ||
| Q3 25 | 7.0% | 34.3% | ||
| Q2 25 | 3.7% | 34.0% | ||
| Q1 25 | 5.4% | 24.7% | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 4.2% | — |
净利率NATRRHLD
| Q4 25 | 3.3% | -1.5% | ||
| Q3 25 | 4.2% | -0.2% | ||
| Q2 25 | 4.6% | -0.5% | ||
| Q1 25 | 4.2% | -3.2% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 2.1% | — |
每股收益（稀释后）NATRRHLD
| Q4 25 | $0.23 | $-0.20 | ||
| Q3 25 | $0.30 | $-0.03 | ||
| Q2 25 | $0.28 | $-0.07 | ||
| Q1 25 | $0.25 | $-0.39 | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.12 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $161.6M | $6.5M |
| 总资产 | $261.1M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资NATRRHLD
| Q4 25 | $93.9M | $205.5M | ||
| Q3 25 | $95.6M | $148.0M | ||
| Q2 25 | $81.3M | $99.9M | ||
| Q1 25 | $86.5M | $71.0M | ||
| Q4 24 | $84.7M | — | ||
| Q3 24 | $78.7M | — | ||
| Q2 24 | $68.7M | — | ||
| Q1 24 | $77.8M | — |
总债务NATRRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
股东权益NATRRHLD
| Q4 25 | $161.6M | $6.5M | ||
| Q3 25 | $166.7M | $10.8M | ||
| Q2 25 | $163.7M | $9.6M | ||
| Q1 25 | $167.1M | $8.9M | ||
| Q4 24 | $161.0M | — | ||
| Q3 24 | $162.6M | — | ||
| Q2 24 | $156.4M | — | ||
| Q1 24 | $159.7M | — |
总资产NATRRHLD
| Q4 25 | $261.1M | $333.4M | ||
| Q3 25 | $264.8M | $293.2M | ||
| Q2 25 | $254.9M | $253.3M | ||
| Q1 25 | $252.7M | $214.3M | ||
| Q4 24 | $240.9M | — | ||
| Q3 24 | $245.3M | — | ||
| Q2 24 | $235.8M | — | ||
| Q1 24 | $247.3M | — |
负债/权益比NATRRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $7.6M | $189.2M |
| 自由现金流率自由现金流/营收 | 6.1% | 160.8% |
| 资本支出强度资本支出/营收 | 1.9% | 5.8% |
| 现金转化率经营现金流/净利润 | 2.41× | — |
| 过去12个月自由现金流最近4个季度 | $28.8M | $313.2M |
8季度趋势，按日历期对齐
经营现金流NATRRHLD
| Q4 25 | $9.9M | $196.1M | ||
| Q3 25 | $18.5M | $59.6M | ||
| Q2 25 | $4.3M | $48.9M | ||
| Q1 25 | $2.6M | $18.4M | ||
| Q4 24 | $12.2M | — | ||
| Q3 24 | $9.6M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $2.2M | — |
自由现金流NATRRHLD
| Q4 25 | $7.6M | $189.2M | ||
| Q3 25 | $16.8M | $58.6M | ||
| Q2 25 | $3.0M | $47.5M | ||
| Q1 25 | $1.5M | $17.8M | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-1.5M | — |
自由现金流率NATRRHLD
| Q4 25 | 6.1% | 160.8% | ||
| Q3 25 | 13.1% | 48.5% | ||
| Q2 25 | 2.6% | 39.7% | ||
| Q1 25 | 1.3% | 17.1% | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | -1.4% | — |
资本支出强度NATRRHLD
| Q4 25 | 1.9% | 5.8% | ||
| Q3 25 | 1.3% | 0.8% | ||
| Q2 25 | 1.2% | 1.2% | ||
| Q1 25 | 1.0% | 0.6% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.3% | — |
现金转化率NATRRHLD
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RHLD
暂无分部数据
